Geode Capital Management’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $89M | Buy |
5,139,449
+593,401
| +13% | +$8.13M | ﹤0.01% | 1284 |
|
|
2026
Q1 | $56.5M | Buy |
4,546,048
+559,494
| +14% | +$7.51M | ﹤0.01% | 1426 |
|
|
2025
Q4 | $50.2M | Sell |
3,986,554
-48,079
| -1% | -$550K | ﹤0.01% | 1476 |
|
|
2025
Q3 | $40.4M | Buy |
4,034,633
+275,538
| +7% | +$2.47M | ﹤0.01% | 1618 |
|
|
2025
Q2 | $30.4M | Sell |
3,759,095
-66,316
| -2% | -$500K | ﹤0.01% | 1722 |
|
|
2025
Q1 | $32.1M | Buy |
3,825,411
+12,204
| +0.3% | +$102K | ﹤0.01% | 1634 |
|
|
2024
Q4 | $30.2M | Buy |
3,813,207
+26,536
| +0.7% | +$223K | ﹤0.01% | 1732 |
|
|
2024
Q3 | $31.5M | Buy |
3,786,671
+378,136
| +11% | +$2.96M | ﹤0.01% | 1728 |
|
|
2024
Q2 | $21.6M | Buy |
3,408,535
+635,485
| +23% | +$4.03M | ﹤0.01% | 1889 |
|
|
2024
Q1 | $16.8M | Buy |
2,773,050
+333,803
| +14% | +$1.88M | ﹤0.01% | 2026 |
|
|
2023
Q4 | $14.8M | Buy |
2,439,247
+119,037
| +5% | +$530K | ﹤0.01% | 2094 |
|
|
2023
Q3 | $9.79M | Buy |
2,320,210
+125,219
| +6% | +$467K | ﹤0.01% | 2284 |
|
|
2023
Q2 | $6.8M | Buy |
2,194,991
+319,268
| +17% | +$680K | ﹤0.01% | 2528 |
|
|
2023
Q1 | $2.61M | Buy |
1,875,723
+45,625
| +2% | +$90.8K | ﹤0.01% | 2919 |
|
|
2022
Q4 | $3.64M | Buy |
1,830,098
+46,940
| +3% | +$105K | ﹤0.01% | 2827 |
|
|
2022
Q3 | $3.6M | Buy |
1,783,158
+51,590
| +3% | +$145K | ﹤0.01% | 2849 |
|
|
2022
Q2 | $5.51M | Buy |
1,731,568
+18,897
| +1% | +$68.5K | ﹤0.01% | 2648 |
|
|
2022
Q1 | $7.14M | Sell |
1,712,671
-48,386
| -3% | -$214K | ﹤0.01% | 2583 |
|
|
2021
Q4 | $8.44M | Buy |
1,761,057
+141,058
| +9% | +$703K | ﹤0.01% | 2571 |
|
|
2021
Q3 | $8.65M | Sell |
1,619,999
-262,711
| -14% | -$1.32M | ﹤0.01% | 2562 |
|
|
2021
Q2 | $9.64M | Buy |
1,882,710
+60,993
| +3% | +$347K | ﹤0.01% | 2481 |
|
|
2021
Q1 | $12.3M | Buy |
1,821,717
+182,932
| +11% | +$1.01M | ﹤0.01% | 2227 |
|
|
2020
Q4 | $7.49M | Buy |
1,638,785
+39,268
| +2% | +$174K | ﹤0.01% | 2353 |
|
|
2020
Q3 | $6.21M | Sell |
1,599,517
-26,079
| -2% | -$112K | ﹤0.01% | 2266 |
|
|
2020
Q2 | $7.74M | Sell |
1,625,596
-80,966
| -5% | -$333K | ﹤0.01% | 2086 |
|
|
2020
Q1 | $5.94M | Buy |
1,706,562
+193,240
| +13% | +$818K | ﹤0.01% | 2040 |
|
|
2019
Q4 | $7.29M | Buy |
1,513,322
+295,959
| +24% | +$1.03M | ﹤0.01% | 2226 |
|
|
2019
Q3 | $3.53M | Buy |
1,217,363
+171,936
| +16% | +$600K | ﹤0.01% | 2598 |
|
|
2019
Q2 | $7.5M | Buy |
1,045,427
+91,847
| +10% | +$939K | ﹤0.01% | 2137 |
|
|
2019
Q1 | $13.5M | Buy |
953,580
+63,600
| +7% | +$841K | ﹤0.01% | 1691 |
|
|
2018
Q4 | $12M | Buy |
889,980
+108,455
| +14% | +$1.95M | ﹤0.01% | 1661 |
|
|
2018
Q3 | $17.3M | Buy |
781,525
+40,341
| +5% | +$849K | ﹤0.01% | 1507 |
|
|
2018
Q2 | $12.2M | Buy |
+741,184
| New | +$13M | ﹤0.01% | 1724 |
|
Other funds holding AMRX
Geode Capital Management's AMRX Position: Q2 2026 in Review
Geode Capital Management increased its Amneal Pharmaceuticals (AMRX) stake by 13% in Q2 2026, buying an estimated $8.13M and bringing the position to 5,139,449 shares worth $89M. The position accounts for ﹤0.01% of the portfolio, ranked #1284.
Geode Capital Management first reported a position in AMRX in Q2 2018 and has held it in 33 quarters since. 288 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.
- Geode Capital Management held 5,139,449 shares of Amneal Pharmaceuticals worth $89M as of Q2 2026.
- Geode Capital Management bought 593,401 Amneal Pharmaceuticals shares in Q2 2026, an estimated $8.13M.
- Amneal Pharmaceuticals made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #1284 holding.
- Geode Capital Management first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 33 quarters since.
- 288 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.
Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.